- Associated Press - Friday, June 5, 2015

DUBLIN, Ohio (AP) - Cardinal Health will spend about $1.12 billion to buy pharmaceutical distributor The Harvard Drug Group in a deal that aims to build its generic and over-the-counter drug businesses.

Cardinal said Friday that its purchase of the privately-held company based in Livonia, Michigan, will provide it with specialized packaging to help supply hospitals and other institutions. Cardinal says it will use cash and borrowing to buy the drug distributor, which is owned by Court Square Capital Partners.

The Harvard Drug Group brought in about $450 million in revenue last year.

The deal comes a week after health care giant Johnson & Johnson accepted Cardinal’s $1.94 billion offer to buy its Cordis heart devices unit.

Dublin, Ohio-based Cardinal Health Inc. expects to issue about $1.5 billion in new debt for the two deals.

Cardinal Health shares fell 51 cents to $87.10 in morning trading Friday. Its shares are up 23 percent over the past year.


Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide